Mira Pharmaceuticals, Inc (MIRA) insider trading
Every open-market stock purchase and sale by Mira Pharmaceuticals, Inc executives, directors, large shareholders and members of Congress, from SEC Form 4 filings. Sector: Other.
Insider activity at a glance
- No open-market insider trades in the last 12 months.
- Last insider buy: Erez Aminov (CEO), $1.7K, 2 years ago.
Last 12 months: insiders bought $0 (0 buys) and sold $0 (0 sales). Last close $0.63 on Oct 22, 2026.
Recent MIRA insider trades
| Date | Insider | Trade | Value |
|---|---|---|---|
| Jun 12, 2026 | Matthew Paul Del Giudice (Director) | Bought (not open market) | — |
| Jun 12, 2026 | Denil Nanji Shekhat (Director) | Bought (not open market) | — |
| Jun 12, 2026 | Matthew Pratt Whalen (Director) | Bought (not open market) | — |
| Jun 12, 2026 | Edward Clouston MacPherson (Director) | Bought (not open market) | — |
| Mar 30, 2026 | Erez Aminov (CEO) | Bought (not open market) | — |
Who's trading MIRA
- Edward Clouston MacPherson, Director: other filings, last Jun 12, 2026
- Matthew Pratt Whalen, Director: other filings, last Jun 12, 2026
- Matthew Paul Del Giudice, Director: other filings, last Jun 12, 2026
- Denil Nanji Shekhat, Director: other filings, last Jun 12, 2026
- Erez Aminov, CEO: other filings, last Mar 30, 2026
Get free alerts when an insider at Mira Pharmaceuticals, Inc files a new trade →